Other

After inclusion, the subjects will have an OGTT performed in the department of Diabetology. If the glucose blood levels remain normal after the OGTT, the test will be repeated after 12 months. A contr

After inclusion, the subjects will have an OGTT performed in the department of Diabetology. If the glucose blood levels remain normal after the OGTT, the test will be repeated after 12 months. A contr is an intervention with 1 clinical trials. Currently 1 active trials ongoing.

Find Trials

Total Trials

Max Phase

—

Type

DIAGNOSTIC TEST

Molecule

—

Success Metrics

Active Trials

1(100%)

Phase Distribution

Ph not_applicable

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution1 total trials

N/ANon-phased studies

1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(1)

Detailed Status

Recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting1100%

Recent Activity

1 active trials

Showing 1 of 1

recruitingnot_applicable

Screening for Type 2 Diabetes by Oral Glucose Tolerance Test in the Population Groups Not Diagnosed by Fasting Blood Glucose in Guadeloupe

NCT07233434

Clinical Trials (1)

Showing 1 of 1 trials

NCT07233434Not Applicable

Screening for Type 2 Diabetes by Oral Glucose Tolerance Test in the Population Groups Not Diagnosed by Fasting Blood Glucose in Guadeloupe

Recruiting

All 1 trials loaded

Drug Details

Intervention Type: DIAGNOSTIC TEST
Total Trials: 1